Trial intelligence / Profile preview

Supraclavicular block adjuvants in distal radius surgery

IRCT20191104045328N46Phase 3Completed

Sponsor
Arak University of Medical Sciences
Start
Nov 2025
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of dexmedetomidine, dexamethasone, fentanyl, ketorolac and bupivacaine in distal forearm fracture (4 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Mean arterial pressure, Heart rate and 6 more. Started Nov 2025; status: completed.

02

Drugs

dexmedetomidinedexamethasonefentanylketorolacbupivacaine
03

Conditions

distal forearm fracture

Beyond the preview

Go deeper on IRCT20191104045328N46.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191104045328N46.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call